Primary hyperparathyroidism and the risk of fracture: A population-based study

Journal of Bone and Mineral Research

Volumn 14, Issue 10, 1999, Pages 1700-1707

  Khosla, Sundeep ^a   Melton III, L Joseph ^a   Wermers, Robert A ^a   Crowson, Cynthia S ^a   O'Fallon, W Michael ^a   Riggs, B Lawrence ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ALBRIGHT SYNDROME; ARTICLE; CALCIUM BLOOD LEVEL; COLLES FRACTURE; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS FRACTURE; PRIMARY HYPERPARATHYROIDISM; RIB FRACTURE; RISK ASSESSMENT; VERTEBRA FRACTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; FRACTURES, BONE; HUMANS; HYPERPARATHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 0032835427     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.10.1700     Document Type: Article

References (52)

1. Preisman RA, Mehnert JH 1971 A. plethora of primary hyperparathyroidism. Arch Surg 103:12-13.
2. Heath H III, Hodgson SF, Kennedy MA 1980 Primary hyperparathyroidism: Incidence, morbidity, and potential economic impact in a community. N Engl J Med 302:189-193.
3. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III 1997 The rise and fall of primary hyperparathyroidism: A population-based study in Rochester, Minnesota, 1965-92. Ann Intern Med 126:433-440.
4. National Institutes of Health 1991 Consensus development conference statement on primary hyperparathyroidism. J Bone Miner Res 6:S9-S13.
5. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton LJ III 1998 Survival after the diagnosis of hyperparathyroidism: A population-based study. Am J Med 104:115-122.
6. Silverberg SJ, Bilezikian JP 1997 Primary hyperparathyroidism: Still evolving? J Bone Miner Res 12:856-862.
7. Melton LJ III 1996 History of the Rochester Epidemiology Project. Mayo Clin Proc 71:266-274.
8. Melton LJ III 1997 The threat to medical-records research. N Engl J Med 337:1466-1470.
9. Kurland LT, Molgaard CA 1981 The patient record in epidemiology. Sci Am 245:54-63.
10. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III 1992 Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-89. J Bone Miner Res 7:221-227.
11. Melton LJ III, Amadio PC, Crowson CS, O'Fallon WM 1998 Long-term trends in the incidence of distal forearm fractures. Osteoporos Int 8:341-348.
12. Melton LJ III, Atkinson EJ, Madhok R 1996 Downturn in hip fractures incidence. Pub Health Rep 111:146-150.
13. Rose SH, Melton LJ III, Morrey BF, Ilstrup DM, Riggs BL 1982 Epidemiologic features of humeral fractures. Clin Orthop 168:24-30.
14. Melton LJ III, Sampson JM, Morrey BF, Ilstrup DM 1981 Epidemiologic features of pelvic fractures. Clin Orthop 155:43-47.
15. Melton LJ III, Crowson CS, O'Fallon WM 1999 Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 9:29-37.
16. Cox DR 1853 Some simple approximate tests for Poisson variates. Biometrika 40:354-360.
17. Kaplan EL, Meier P 1958 Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
18. Kalbfleisch JD, Prentice RL 1980 Anonymous the Statistical Analysis of Failure Time Data. John Wiley and Sons, New York, NY, U.S.A.
19. Cox DR 1972 Regression models and life-tables (with discussion). J Royal Stat Soc 34B:187-220.
20. Melton LJ III, Atkinson EJ, O'Fallon WM, Heath HI 1992 Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 152:2269-2273.
21. Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E, Persson I 1993 The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow-up of 19 years. J Intern Med 234:585-593.
22. Larsson K, Lindh E, Lind L, Persson I, Ljunghall S 1989 Increased fracture risk in hypercalcemia: Bone mineral content measured in hyperparathyroidism. Acta Orthop Scand 60:268-270.
23. Dauphine RT, Riggs BL, Scholz DA 1975 Back pain and vertebral crush fractures: An unemphasized mode of presentation for primary hyperparathyroidism. Ann Intern Med 83:365-367.
24. Wilson RJ, Rao S, Ellis B, Kleerekoper M, Parfitt AM 1988 Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109:959-962.
25. Kochersberger G, Buckley NJ, Leight GS, Martinez S, Studenski S, Vogler J, Lyles KW 1987 What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 147:1951-1953.
26. Kenny AM, MacGillivray DC, Pilbeam CC, Crombie HD, Raisz LG 1995 Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 118:109-114.
27. Silverberg SJ, Shane E, Cruz LDL, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283-291.
28. Wishart J, Horowitz M, Need A, Nordin BEC 1990 Relationship between forearm and vertebral mineral density in post-menopausal women with primary hyperparathyroidism. Arch Intern Med 150:1329-1331.
29. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL 1982 Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 69:1302-1309.
30. Pfeilschifter J, Siegrist E, Wuster C, Blind E, Ziegler R 1992 Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinol 127:319-323.
31. Guo C, Thomas WEG, Al-Dehaimi AW 1996 Longitudinal changes in bone mineral density and bone turnover in post-menopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 81:3487-3491.
32. Hesp R, Tellez M, Davidson L, Elton A, Reeve J 1987 Trabecular and cortical bone in the radii of women with parathyroid adenomata: A greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy. Bone Miner 2:301-310.
33. Silverberg SJ, Locker FG, Bilezikian JP 1996 Vertebral osteopenia: A new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007-4012.
34. Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL, Mazess RB, Johnson KA, Melton LJ III 1982 Changes in bone mineral density of the proximal femur and spine with aging: Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest 70:716-723.
35. Eastell R, Wahner HW, O'Fallon WM, Amadio PC, Melton LJ III, Riggs BL 1989 Unequal decrease in bone density of lumbar spine and ultradistal radius in Colles' and vertebral fracture syndromes. J Clin Invest 83:168-174.
36. Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL 1988 Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: Effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 66:951-957.
37. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP 1992 Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 74:481-486.
38. Silverberg SJ, Deftos LJ, Kim T, Hill CS 1991 Bone alkaline phosphatase in primary hyperparathyroidism. J Bone Miner Res 6:A624.
39. Riggs BL, Melton LJ III, O'Fallon WM 1996 Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 18:1975-2015.
40. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 11:1531-1538.
41. Parfitt AM 1984 Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences. Calcif Tissue Int 36:S123-S128.
42. Einhorn TA 1992 Bone strength: The bottom line. Calcif Tissue Int 51:333-339.
43. Parisien M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP 1995 Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 10:1393-1399.
44. Parisien M, Silverberg SJ, Shane E, De La Cruz L, Lindsay R, Bilezikian JP, Dempster DW 1990 The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930-938.
45. Parisien M, Mellish RWE, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW 1992 Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis. J Bone Miner Res 7:913-919.
46. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, McMahon DJ, Bilezikian JP 1995 Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80:729-734.
47. Finkelstein JS, Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM 1998 Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): A randomized controlled trial. JAMA 280:1067-1073.
48. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550-555.
49. Dempster D, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709.
50. Tam CS, Heersche JNM, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512.
51. Canalis E, Centrella M, Burch W, McCarthy TL 1988 Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65.
52. Kronenberg HM 1997 Editorial: Parathyroid hormone and osteocalcin - When friends become strangers. Endocrinology 138:3083-3084.